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Abstract Chemical insecticides are the mainstay of
contemporary control of human disease vectors.
However, the spread of insecticide resistance and the
emergence of new disease threats are creating an
urgent need for alternative tools. This perspective
paper explores whether biological control might be
able to make a greater contribution to vector control in
the future, and highlights some of the challenges in
taking a technology from initial concept through to
operational use. The aim is to stimulate a dialogue
within biocontrol and vector control communities, in
order to make sure that biological control tools can
realize their full potential.
Keywords Vector-borne diseases  Insecticide
resistance  Biocontrol  Mosquito  Integrated Vector
Management
Introduction
Contemporary control of human disease vectors relies
almost exclusively on insecticide-based interventions.
This situation is especially true for malaria vectors, but
applies also to vectors of other human diseases such as
dengue, Zika, Chagas, leishmaniasis, etc., as well as to
some livestock diseases. This paper examines whether
biological control could play an increased role in
vector control and contribute to the development of
sustainable Integrated Vector Management (IVM)
strategies in which diverse tools, tactics, and resources
are combined to reduce transmission of disease by
vectors. Looking at parallels with agriculture and the
established role of biological control in development
of Integrated Pest Management (IPM) strategies, a role
in IVM ought to be possible (Thomas et al. 2012). Yet
in reality there are very few examples where biological
control is playing an established role in vector control.
This paper examines why this might be the case. The
approach is not to present a review of the diverse
research studies conducted over the years on biolog-
ical control approaches, in part because this literature
is reviewed elsewhere (e.g., Chapman 1985; McGraw
and O’Neill 2013; Benelli et al. 2016; Huang et al.
2017; Saldaña et al. 2017). Rather, this paper aims to
highlight some of the opportunities but also the
challenges in developing a biological control tool or
tactic to the point of operational use.
The paper is framed around the following assump-
tions and caveats:
(i) The insights derive largely from work on the
ecology and control of adult malaria mosqui-
toes. Other disease vectors, such as the Aedes
spp. responsible for transmitting dengue,
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chikungunya and Zika viruses, have different
ecologies and so control tools or approaches
might not necessarily transfer between sys-
tems. However, the key challenges for devel-
oping a control tool through to operational
use (namely demonstrating efficacy, defining
a clear role within IVM, regulatory approval
and implementation) are similar across vector
borne disease systems.
(ii) The definition of biological control used in
this paper centers on the use of predators,
parasites, or pathogens, where the mode of
action relies on the living organisms and not
simply their derivatives. This definition puts
pesticides based on the toxin-forming bacte-
ria Bacillus thuringiensis and B. sphaericus
at the margins of biological control, which is
not to say they are not valuable technologies,
but the aim of this paper is to look at
opportunities beyond these established prod-
ucts. Use of toxins derived from plants or
microbes, or insecticide juvenile hormone
analogues are not considered biological con-
trol, even though these are often referred to as
‘biological’ products.
(iii) The definition of biological control also
excludes transgenic and gene drive technolo-
gies where the vector itself is genetically
modified for the purpose of population sup-
pression or population replacement strate-
gies, since there is no natural enemy
involved. Conventional sterile insect tech-
nique is excluded for similar reasons. Other
recent reviews (e.g., Benelli et al. 2016;
Huang et al. 2017) have taken a more
pluralistic view of biological control to
include these ‘biologically-based’ strategies.
However, the long-standing definition of
biological control centers on the use of a
natural enemy and not modification of the
pest itself. This definition is consistent with
the policy of the current journal and the
International Organisation for Biological
Control (IOBC). On the other hand, novel
approaches like trans-infection of vectors
with an endosymbiont such as Wolbachia
(McMeniman et al. 2009; Hoffmann et al.
2011), or paratransgenisis, where a pathogen
or parasite is genetically modified in some
way to affect the capacity of the vector to
transmit the target disease (Wilke and Mar-
relli 2015), are included as they do use a
living parasite to effect change in another
target organism.
Opportunities for new tools for the control
of disease vectors
Recent years have seen dramatic reductions in the
burden of malaria worldwide. The decline is largely
attributable to the broad-scale use of long lasting
insecticide treated nets (LLINs) and indoor residual
sprays (IRS) against adult mosquitoes (Bhatt et al.
2015). The success of these insecticide-based inter-
ventions represents a foundational step in the global
agenda to eliminate malaria. However, the current
control tools alone are likely insufficient to eliminate
malaria in many settings, even if their use could be
intensified further (malERA Consultative Group on
Vector Control 2011; WHO 2015; Griffin et al. 2016).
Additionally, there is a growing problem of insecticide
resistance that could render existing tools ineffective
and potentially lead to a reversal of recent gains (WHO
2015; Griffin et al. 2016; Hemingway et al. 2016).
Similar challenges exist for control of arboviruses
such as dengue, chikungunya and Zika, which have
emerged as major threats to public health in recent
years. In the absence of effective drugs and vaccines,
the ability to combat these diseases relies on vector
control (Yakob and Walker 2016). Again, chemical
insecticides, the current mainstay, are being under-
mined by the evolution of insecticide resistance (Lima
et al. 2011; Bellinato et al. 2016; Duong et al. 2016;
Ishak et al. 2017). Moreover, the key mosquito vectors
of these arboviruses, Aedes aegypti and A. albopictus,
continue to spread into new areas, including parts of
Europe and the US (Kraemer et al. 2015). Other
emerging diseases, such as West Nile virus (transmit-
ted by a diversity of mosquito species) (Paz 2015) and
Lyme disease (transmitted by certain ticks) (Ostfeld
and Brunner 2015) are also extending the threat of
vector-borne diseases into temperate environments not
typically associated with vector borne disease prob-
lems in recent history. These challenges create a
demand for new control tools, and could increase
opportunities for biological control.
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Building a role for biological control
Making the case
There is no reason a priori why biological control
technologies cannot offer new tools and strategies, and
contribute to the development of IVM strategies that
reduce the reliance on insecticide-based interventions.
However, the track record of biological control in
vector control is limited, especially if we exclude the
bacterial pesticides B. thuringiensis and B. sphaericus.
Without a pedigree, there is no major incentive for the
public health community to look to biological control
for answers. Many decades of chemical control have
created a pesticide mindset. Similar mindset limits the
adoption of biological control tools in certain agricul-
tural sectors (van Lenteren 2012).
The ‘organic’ or ‘green’ economic premiums that
can help drive the adoption of biological control
approaches in agriculture and natural environments do
not carry the same weight in vector control. National
vector borne disease control programs tend to operate
on limited budgets within the context of public health
systems. In many settings, the householders make no
direct financial contribution for an intervention so
there is minimal capacity to pass on control costs to the
‘consumer’. Furthermore, while an individual house-
holder can make a choice to buy organic produce, that
same householder cannot choose the nature of the
vector control products or strategy delivered at the
community level. Perhaps most fundamentally, cur-
rent vector control is dominated by short-term eco-
nomics, with products most frequently purchased via a
tender process that emphasizes minimum cost for
maximum coverage. This approach constrains inno-
vation and provides little incentive for technologies
that might have added value or contribute to a ‘public
good’, such as increased environmental or evolution-
ary sustainability.
Additionally, there are many ways to kill a
mosquito or otherwise disrupt transmission. Develop-
ing novel chemical actives is an obvious route and has
been a primary focus of initiatives such as the
Innovative Vector Control Consortium (IVCC) (Hem-
ingway et al. 2006). Diverse alternative technologies
such as toxic sugar baits (Müller et al. 2010), house
screening/modification (Kirby et al. 2009; Knols et al.
2016), endectocides (Chaccour et al. 2013), repellants
(Achee et al. 2012), lethal ovitraps (Paz-Soldan et al.
2016), mass trapping (Homan et al. 2016), genetic
control strategies (reviewed in McGraw and O’Neill
2013), etc. are all the subject of ongoing research.
Against this backdrop, it is not obvious why either
industry or government should single out biological
control solutions over other alternative technologies.
Research and Development (R&D) budgets are finite
and there are likely trade-offs in funding at some level.
The fact that a biological control technology ‘can’ be
developed is not necessarily sufficient. There needs to
be a justification for why a biological control
technology ‘should’ be developed. Depending on the
particular approach and system, the reasons could be
manifold, including: self–sustaining, self–spreading,
non-chemical, lack of any alternative tool, resilient to
evolution of resistance, overcoming insecticide resis-
tance, cheap, novel delivery systems, complementary
to conventional tools, targeting residual transmission,
potential for community engagement, local production
and ownership, donor-driven, etc. Whatever the rea-
son(s), the case needs to be clear.
Demonstrating efficacy
A frequent starting point for developing a technology
is to evaluate it in the laboratory. If it doesn’t work in
the laboratory, where conditions are highly controlled,
it probably isn’t going to work in the field. However, a
substantial and rigorous body of evidence is required
to obtain approval and ultimate use of a technology or
approach by the likes of The World Health Organi-
sation (WHO), funding agencies, regulatory authori-
ties and national programs.
The generally accepted gold standard for demon-
strating efficacy of a public health intervention is a
randomized controlled trial (RCT) with epidemiolog-
ical end points. Building a product or approach and
progressing from basic phase I lab studies, through
phase II semi-field studies, up to a full-blown phase III
RCT is challenging. It takes time, multiple granting
successes and substantial resources. This situation is
not unique to biological control and is recognized as a
major challenge for development of novel public
health tools. For new tools that fit with established
paradigms, there are efforts to streamline the evalu-
ation pathway (Vontas et al. 2014). For example, a
new chemical active ingredient for use in indoor
residual spraying (IRS) might not need a phase III trial
as IRS itself is a proven approach and whether the new
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active performs better than an existing product can
likely be demonstrated in a phase II equivalency test.
However, where the paradigms are novel and there are
no clear reference points, evidence of epidemiological
impact is likely required (Vontas et al. 2014).
While the need for rigorous evaluation is also true
in agriculture, there are some important differences
between agriculture and public health. First, although
not universally true, demonstrating the impact of a
pest control tool in agriculture might well be possible
in relatively small replicated plots within or across
individual fields or glasshouses. The epidemiology of
diseases such as malaria or dengue tends to play out
over larger scales. Second, agriculture is more
accepting of intermediate end points, such as reduc-
tions in pest density, without necessarily demonstrat-
ing definitive impact on crop yield or profit margin for
the grower. In public health, the primary end points
usually relate to one or more measures of disease
burden within the human population, and entomolog-
ical end points alone are usual viewed as insufficient.
Very few biological control interventions for vector
borne diseases have progressed to the level of
evaluating epidemiological outcomes. Even the Elim-
inate Dengue Program (http://www.eliminatedengue.
com/program), which is one of the largest and most
high profile programs to explore a new mosquito
control intervention in recent years, has yet to
demonstrate epidemiological impact, though this
research is ongoing. Moreover, many field studies
examining intermediate entomological end points are
poorly designed with insufficient power, inappropriate
controls and inadequate monitoring. For example,
biological control of mosquito larvae using fish has
been researched for decades. In 2013 a Cochrane
review was conducted to examine whether there was
evidence that introducing larvivorous fish to anophe-
line breeding sites impacted malaria transmission or
influenced adult anopheline density (Walshe et al.
2013). The review examined nearly 1300 published
articles. There was not one reliable study that reported
effects on malaria transmission. Only 12 studies were
of sufficient quality to determine impacts on mosquito
larval and pupal densities but the results themselves
were inconclusive. The authors conclude that reliable
research is insufficient to show whether introducing
fish reduces transmission or density of malaria mos-
quito populations. Similarly, meta-analysis on use of
invertebrate (copepod) larval predators against dengue
vectors also reveals no clear evidence for policy rec-
ommendations (Lazaro et al. 2015).
Multiple proof-of-principle studies that provide
evidence to support further development of a technol-
ogy are not substitutes for proper efficacy trials. Fewer
well-conducted trials (whether small or large-scale)
would do more to strengthen the case for biological
control than numerous poorly conducted trials. The
fact that results might be mixed is not necessarily a bad
thing, depending on the reasons for the variability. A
technology that is inherently unreliable is not the same
as a technology that works well but only does so under
a certain set of ecological or socio-economic condi-
tions (Klass et al. 2007). It is important that evaluation
takes local context into account. Niche products could
be very valuable as long as the niche can be
characterized. There is now growing acceptance in
the vector control community of the need for local
optimization of technologies (Dicko et al. 2014;
Mnzava et al. 2014; WHO 2015), a concept appreci-
ated in biological control and IPM (e.g., Thomas et al.
2012; Harris et al. 2013; Parsa et al. 2014; Barzman
et al. 2015; Guedes et al. 2016).
Operational considerations
One component of technology development that is
often neglected, particularly in initial stages of a
project, is consideration of operational use. For
example, numerous studies identify fungal pathogens
as potential biological control agents for use against
mosquito larvae (e.g., Pereira et al. 2009; Seye et al.
2013; Vogels et al. 2014; Greenfield et al. 2015;
Alkhaibari et al. 2016). Yet there already exist non-
chemical products, such as B. thuringiensis and B.
sphaericus, which can work very well in certain
settings (reviewed in Benelli et al. 2016). There are
also numerous chemical insecticides, including insect
growth regulators with modes of action distinct from
standard neurotoxins (Devine et al. 2009; Devine
2016). However, the key challenge for larval control
of mosquito vectors is not necessarily the lack of
candidate products but the ability to deliver them in a
cost-effective manner to breeding habitats that can be
highly numerous, difficult to locate and transient. If
the habitats cannot be treated because they are
inaccessible or too numerous, or if the product requires
frequent re-treatment because it does not persist, there
is not obviously an advantage over current tools.
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The need to consider operational use is not limited
to larval control. For example, there is a growing
interest in developing sugar baits as novel delivery
systems for both chemical actives and biologicals
(Müller et al. 2010; Beier et al. 2012; Marshall et al.
2013; Ondiaka et al. 2015; Dennison et al. 2016). One
of the key challenges for this approach is whether
artificial bait stations can compete against diverse
sources of sugar available in the natural environment.
Putting a biological control agent in a bait station does
not necessarily address this problem. Furthermore,
whether using a bait station to deliver something like a
bacterium to alter susceptibility of mosquitoes to
malaria parasites (Dennison et al. 2016) offers
substantial advantages over a simple stomach poison
which kills mosquitoes (males and females) directly is
uncertain, not only in terms of efficacy but also in
terms of key operational considerations such as
production, formulation, supply chain and persistence.
These examples re-emphasize the need to identify
what it is that a biological control approach is bringing
to the table. Potential control benefits have to be
weighed against operational challenges in order to
define the overall rationale for development. Part of
the rationale should involve a consideration of how
much research and development is required to make
the technology or strategy field-ready. Our capacity to
continue to drive down malaria in the face of
insecticide resistance requires new tools to be oper-
ational within the next 5–10 years (WHO 2015;
Griffin et al. 2016). Given this pressing timeline, there
is a strong argument for properly evaluating tools that
have an existing R&D foundation on which to build.
For example, in the last ten years there has been a
substantial body of work exploring the potential for
use of fungal pathogens against adult mosquitoes. The
approach builds on the fact that commercial biopes-
ticide products based on fungal pathogens exist
already in agriculture. Numerous studies now provide
evidence that fungal pathogens can reduce the vecto-
rial capacity of mosquitoes (e.g. Blanford et al. 2005;
Scholte et al. 2005; Lynch et al. 2012; Mnyone et al.
2012; Heinig et al. 2015); can infect diverse mosquito
species, including strains resistant to insecticides (e.g.
Scholte et al. 2007; Farenhorst et al. 2009; Howard
et al. 2010; Blanford et al. 2011; Darbro et al. 2012);
can be used in a variety of potential delivery strategies
(e.g. Scholte et al. 2005; Blanford et al. 2012; Mnyone
et al. 2012; Darbro et al. 2012; Carolino et al. 2014;
Sternberg et al. 2016); and can satisfy important
operational criteria such as storage, persistence and
safety (e.g. Zimmermann 2007; Darbro and Thomas
2009; Blanford et al. 2012). There is little in this
baseline research to suggest that products based on
entomopathogenic fungi (which might be residual
sprays or point source targets) could not be opera-
tionalized, and might be especially valuable in devel-
opment of resistance management strategies requiring
diverse products for use in rotations, mixtures or
mosaics. Some additional effort towards large-scale
field evaluation of fungi in the next 1–3 years,
including operational feasibility and economic assess-
ments, could provide the remaining evidence to either
support implementation, or discount the approach
once and for all. This is not to say that fungal
pathogens are the only prospective tool with an
existing research foundation. They are simply an
illustration. Nor is it an argument that genuinely new
approaches, which might take ten years or more to be
field-ready, should not be explored. However, there is
a tendency to be seduced by the next ‘big idea’, yet the
timeline to implementation needs to be considered.
Regulation and approvals
Funding for malaria control comes in large part from
the donor community including The Global Fund, The
World Bank, and bilateral country-to-country assis-
tance. In order for products or interventions to receive
donor support there is a general requirement that they
have been evaluated to a sufficient standard to obtain
recommendation from WHO. Initial evaluation of
novel control tools that do not conform to conven-
tional chemical insecticide target product profiles is
the responsibility of the Vector Control Advisory
Group (VCAG) (Vontas et al. 2014). The role of
VCAG is to communicate with innovators on the
development of early-stage vector control paradigms,
assess the data to determine whether the evidence
about the intervention is sufficient to justify its
potential application, and make a recommendation to
the Malaria Policy Advisory Committee of the Global
Malaria Programme and/or the Strategic and Techni-
cal Advisory Group of the Department of Control of
Neglected Tropical Diseases for ultimate public health
policy recommendation.
The VCAG is a relatively new initiative so as yet
there are very few biological control approaches
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under evaluation, but moving forward it will be
important for novel biological control interventions
to be submitted to the VCAG at an early stage of
development to guide the R&D. The current frame-
work for evaluation requires a substantial body of
evidence, including at least some indication of the
epidemiological outcome. Approval depends on
whether the intervention is considered ‘‘efficacious
for some defined public health purpose (in disease
prevention through vector control) and in some
defined circumstances’’ and whether it will be
‘‘useful to and feasible for its intended users’’.
One of the challenges with these criteria is the
evaluation technologies that might not perform
sufficiently well in terms of efficacy or cost to
justify stand-alone use, but might nonetheless make
a significant contribution in the context of broader
resistance management or IVM strategies. For
example, a parasite or pathogen might not be
sufficiently cost-effective to use as a direct alterna-
tive for a chemical product, but its value might
come from use in a rotation strategy where it slows
evolution of insecticide resistance and prolongs the
useful lifespan of the cheaper chemical. This
situation calls for the need for ‘value-based’, rather
than simple ‘cost-based’ decision-making.
Finally, in most settings, ultimate adoption of an
intervention requires regulatory approval at the
national level. Most countries have established
regulatory frameworks for evaluating pesticides but
equivalent frameworks for biological control agents
are often lacking or inconsistent. Additional chal-
lenges can occur when a particular technology does
not fit exactly within any existing regulatory
framework, as was the case for initial introductions
of Wolbachia trans-infected Aedes agypti into Aus-
tralia (Murray et al. 2016). Complexities will likely
increase much further if the approach involves
genetic modification. Important to recognize here
is that extra layers of risk assessment and potentially
uncharted regulatory pathways could add years to
the implementation timeline. This concern does not
mean that transgenic or paratransgenic approaches
are not worth pursuing, but it creates additional
challenges for whether such technologies might
ultimately be able to make a contribution to control,
and increases the burden on the initial justification
for development.
Conclusions
There are many papers published every year reporting
some new idea that ‘‘could play a role in future control
of malaria vectors’’, including (but definitely not
restricted to) prospective biological control tools. Yet
it is difficult to think of anything genuinely novel that
has made it into wide scale operational use in the last
20 years. There are multiple reasons for this limited
impact. To take a product from initial concept through
to operational use usually requires years of R&D.
There are very few opportunities for large grants, and
maintaining continuous support over multiple small
grants is difficult, particularly when there is a large
stochastic element to funding. Sustaining the research
effort through this process is also challenging, espe-
cially in academic environments where promotion and
tenure processes tend to orient researchers towards
short-term outputs such as publications and patents,
rather than longer-term outcomes such as products or
changes in practice. Yet potential industry partners
want technologies to be developed as far as possible so
that they know what they’re getting and there is little
risk. Product development partnerships such as the
Innovative Vector Control Consortium aim to help
bridge this translational divide and their portfolio is
now extending beyond conventional chemical
approaches to include novel paradigms. More broadly,
new initiatives, such as Innovation to Impact (http://
innovationtoimpact.org/), are being developed to
address challenges across all segments of the vector
control pathway including innovation, evaluation
(assessment for safety, efficacy and quality), regis-
tration, procurement, and impact. However, these
initiatives are still very product/market-driven and
there are additional challenges for knowledge-driven
approaches that fall outside conventional public health
paradigms. It is not clear, for example, how a strategy
based on augmentation of natural enemies, or manip-
ulation of a house or environmental feature fit within
this product-oriented landscape. To some extent there
are parallels here with the ‘top down’ implementation
pathways that have promoted wide scale use of
chemical pesticides in conventional agriculture, ver-
sus more participatory ‘bottom-up’ approaches, which
can enable development of more diverse, knowledge-
intensive IPM strategies tailored to the local context
(Thomas et al. 2012).
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Given these challenges, there is a need for
realism and some critical self-evaluation of how
and when a new tool might contribute to vector
control, an argument not limited to biological
control. If there is a genuine expectation to move
from innovation to implementation, researchers and
funding agencies should be asking whether the
technology or approach is likely to have an
epidemiological impact, is there a need for it or is
it simply technology-driven, can it be made oper-
ational in the field, what will it take to be
implemented within existing control frameworks
(which includes considerations of logistics, capacity,
cost and value), what are the regulatory hurdles,
how much money will it cost to develop and how
long will it take? This might seem like a demanding
list and it is not the intention to put barriers in front
of fundamental research or to constrain technology
innovation. However, the lack of any genuinely
novel control tool on the ground in that last 20 years
points to a need for critical assessment of prospec-
tive approaches and the mechanisms of research
translation. On the positive side, biological control
has established itself in agriculture and environmen-
tal management in spite of very similar challenges
of limited funding, demanding timelines, regulatory
hurdles, operational constraints, complex cost-bene-
fit relationships (Cock et al. 2010), etc. Can some of
this knowledge and experience be transferred to
public health?
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Seye F, Ndione RD, Touré M, Ndiaye M, Boukraa S, Bawin T,
Zimmer JY, Francis F (2013) Laboratory and semi-field
environment tests for the control efficacy of Metarhizium
anisopliae formulated with neem oil (suneem) against
Anopheles gambiae sl adult emergence. Acad J Biotechnol
1:46–52
Sternberg ED, Ng’habi KR, Lyimo IN, Kessy ST, Farenhorst M,
Thomas MB, Knols BG, Mnyone LL (2016) Eave tubes for
malaria control in Africa: initial development and semi-
field evaluations in Tanzania. Malar J 15(1):447
ThomasMB, Godfray HC, Read AF, van den Berg H, Tabashnik
BE, van Lenteren JC, Waage JK, Takken W (2012) Les-
sons from agriculture for the sustainable management of
malaria vectors. PLoS Med 9(7):e1001262
van Lenteren JC (2012) The state of commercial augmentative
biological control: plenty of natural enemies, but a frus-
trating lack of uptake. BioControl 57(1):1–20
Vogels CB, Bukhari T, Koenraadt CJ (2014) Fitness conse-
quences of larval exposure to Beauveria bassiana on adults
of the malaria vector Anopheles stephensi. J Invertebr
Pathol 119:19–24
Vontas J, Moore S, Kleinschmidt I, Ranson H, Lindsay S,
Lengeler C, Hamon N, McLean T, Hemingway J (2014)
Framework for rapid assessment and adoption of new
vector control tools. Trends Parasitol 30:191–204
Walshe DP, Garner P, Abdel-Hameed Adeel AA, Pyke GH,
Burkot T (2013) Larvivorous fish for preventing malaria
transmission. Cochrane Database Syst Rev 12(1):1–65
Wilke AB, Marrelli MT (2015) Paratransgenesis: a promising
new strategy for mosquito vector control. Parasit Vectors
8(1):342
World Health Organization (2015) Global technical strategy for
malaria 2016-2030. World Health Organization, Geneva
Yakob L, Walker T (2016) Zika virus outbreak in the Americas:
the need for novel mosquito control methods. Lancet Glob
Health 4:e148–e149
Zimmermann G (2007) Review on safety of the ento-
mopathogenic fungi Beauveria bassiana and Beauveria
brongniartii. Biocontrol Sci Technol 17:553–596
Matthew Thomas is a Professor of entomology and Huck
Scholar at Penn State University, USA. Research in his group
explores many aspects of the ecology and evolution of insect
pests and diseases with the aim of better understanding the
consequences of global change, and improving the effective-
ness and sustainability of pest and disease management.
Biological control of human disease vectors: a perspective on challenges and opportunities 69
123
